8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Gliotoxicity and Glioprotection: the Dual Role of Glial Cells

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Glial cells (astrocytes, oligodendrocytes and microglia) are critical for the central nervous system (CNS) in both physiological and pathological conditions. With this in mind, several studies have indicated that glial cells play key roles in the development and progression of CNS diseases. In this sense, gliotoxicity can be referred as the cellular, molecular, and neurochemical changes that can mediate toxic effects or ultimately lead to impairment of the ability of glial cells to protect neurons and/or other glial cells. On the other hand, glioprotection is associated with specific responses of glial cells, by which they can protect themselves as well as neurons, resulting in an overall improvement of the CNS functioning. In addition, gliotoxic events, including metabolic stresses, inflammation, excitotoxicity, and oxidative stress, as well as their related mechanisms, are strongly associated with the pathogenesis of neurological, psychiatric and infectious diseases. However, glioprotective molecules can prevent or improve these glial dysfunctions, representing glial cells-targeting therapies. Therefore, this review will provide a brief summary of types and functions of glial cells and point out cellular and molecular mechanisms associated with gliotoxicity and glioprotection, potential glioprotective molecules and their mechanisms, as well as gliotherapy. In summary, we expect to address the relevance of gliotoxicity and glioprotection in the CNS homeostasis and diseases.

          Related collections

          Most cited references195

          • Record: found
          • Abstract: found
          • Article: not found

          Inflammaging: a new immune–metabolic viewpoint for age-related diseases

          Ageing and age-related diseases share some basic mechanistic pillars that largely converge on inflammation. During ageing, chronic, sterile, low-grade inflammation - called inflammaging - develops, which contributes to the pathogenesis of age-related diseases. From an evolutionary perspective, a variety of stimuli sustain inflammaging, including pathogens (non-self), endogenous cell debris and misplaced molecules (self) and nutrients and gut microbiota (quasi-self). A limited number of receptors, whose degeneracy allows them to recognize many signals and to activate the innate immune responses, sense these stimuli. In this situation, metaflammation (the metabolic inflammation accompanying metabolic diseases) is thought to be the form of chronic inflammation that is driven by nutrient excess or overnutrition; metaflammation is characterized by the same mechanisms underpinning inflammaging. The gut microbiota has a central role in both metaflammation and inflammaging owing to its ability to release inflammatory products, contribute to circadian rhythms and crosstalk with other organs and systems. We argue that chronic diseases are not only the result of ageing and inflammaging; these diseases also accelerate the ageing process and can be considered a manifestation of accelerated ageing. Finally, we propose the use of new biomarkers (DNA methylation, glycomics, metabolomics and lipidomics) that are capable of assessing biological versus chronological age in metabolic diseases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Microglia Function in the Central Nervous System During Health and Neurodegeneration.

            Microglia are resident cells of the brain that regulate brain development, maintenance of neuronal networks, and injury repair. Microglia serve as brain macrophages but are distinct from other tissue macrophages owing to their unique homeostatic phenotype and tight regulation by the central nervous system (CNS) microenvironment. They are responsible for the elimination of microbes, dead cells, redundant synapses, protein aggregates, and other particulate and soluble antigens that may endanger the CNS. Furthermore, as the primary source of proinflammatory cytokines, microglia are pivotal mediators of neuroinflammation and can induce or modulate a broad spectrum of cellular responses. Alterations in microglia functionality are implicated in brain development and aging, as well as in neurodegeneration. Recent observations about microglia ontogeny combined with extensive gene expression profiling and novel tools to study microglia biology have allowed us to characterize the spectrum of microglial phenotypes during development, homeostasis, and disease. In this article, we review recent advances in our understanding of the biology of microglia, their contribution to homeostasis, and their involvement in neurodegeneration. Moreover, we highlight the complexity of targeting microglia for therapeutic intervention in neurodegenerative diseases. Expected final online publication date for the Annual Review of Immunology Volume 35 is April 26, 2017. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Reactive astrocyte nomenclature, definitions, and future directions

              Reactive astrocytes are astrocytes undergoing morphological, molecular, and functional remodeling in response to injury, disease, or infection of the CNS. Although this remodeling was first described over a century ago, uncertainties and controversies remain regarding the contribution of reactive astrocytes to CNS diseases, repair, and aging. It is also unclear whether fixed categories of reactive astrocytes exist and, if so, how to identify them. We point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic-vs-neuroprotective or A1-vs-A2. We advocate, instead, that research on reactive astrocytes include assessment of multiple molecular and functional parameters—preferably in vivo—plus multivariate statistics and determination of impact on pathological hallmarks in relevant models. These guidelines may spur the discovery of astrocyte-based biomarkers as well as astrocyte-targeting therapies that abrogate detrimental actions of reactive astrocytes, potentiate their neuro- and glioprotective actions, and restore or augment their homeostatic, modulatory, and defensive functions.
                Bookmark

                Author and article information

                Contributors
                andrequincozes@ufrgs.br
                Journal
                Mol Neurobiol
                Mol Neurobiol
                Molecular Neurobiology
                Springer US (New York )
                0893-7648
                1559-1182
                28 September 2021
                : 1-16
                Affiliations
                [1 ]GRID grid.8532.c, ISNI 0000 0001 2200 7498, Programa de Pós-Graduação Em Ciências Biológicas: Bioquímica, , Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul, ; Porto Alegre, RS Brazil
                [2 ]GRID grid.8532.c, ISNI 0000 0001 2200 7498, Departamento de Bioquímica, , Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul, ; Porto Alegre, RS Brazil
                [3 ]GRID grid.8532.c, ISNI 0000 0001 2200 7498, Programa de Pós-Graduação Em Neurociências, , Instituto de Ciências Básicas da Saúde, Universidade Federal Do Rio Grande Do Sul, ; Porto Alegre, RS Brazil
                Author information
                http://orcid.org/0000-0001-8611-4890
                http://orcid.org/0000-0001-9438-0638
                http://orcid.org/0000-0002-1001-5068
                http://orcid.org/0000-0001-5258-9572
                http://orcid.org/0000-0003-4377-2329
                http://orcid.org/0000-0002-9487-2701
                http://orcid.org/0000-0001-6001-0567
                http://orcid.org/0000-0001-6083-9105
                http://orcid.org/0000-0003-0058-5929
                http://orcid.org/0000-0002-7961-1538
                http://orcid.org/0000-0002-2054-4190
                http://orcid.org/0000-0001-8901-1205
                http://orcid.org/0000-0003-0155-8375
                http://orcid.org/0000-0001-8318-4818
                Article
                2574
                10.1007/s12035-021-02574-9
                8477366
                34581988
                8044e464-5374-492a-b9c3-efe10c268a28
                © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 22 July 2021
                : 19 September 2021
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004909, universidade federal do rio grande do sul;
                Funded by: FundRef http://dx.doi.org/10.13039/501100003593, conselho nacional de desenvolvimento científico e tecnológico;
                Funded by: FundRef http://dx.doi.org/10.13039/501100002322, coordenação de aperfeiçoamento de pessoal de nível superior;
                Funded by: FundRef http://dx.doi.org/10.13039/501100004263, fundação de amparo à pesquisa do estado do rio grande do sul;
                Categories
                Article

                Neurosciences
                glial cells,gliotoxicity,glioprotection,glioprotective molecules
                Neurosciences
                glial cells, gliotoxicity, glioprotection, glioprotective molecules

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content644

                Cited by12

                Most referenced authors1,943